Followers | 0 |
Posts | 13277 |
Boards Moderated | 0 |
Alias Born | 05/06/2016 |
Tuesday, December 20, 2016 11:18:20 PM
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=160529
Item 1: Completion of Disposition of Assets
On August 22, 2016, it was announced that Manzo Pharmaceuticals CEO Kenneth Manzo Milford, the Issuer's Chief Executive Officer resigned in connection with a settlement with the U.S. Securities and Exchange Commission (SEC). The SEC settlement bars Mr. Manzo from being an officer or director of the Issuer.
The Issuer was dependent upon the personal financial support of Mr. Manzo, who had never taken any salary. The Issuer cannot develop its business plan without the services and funding of Mr. Manzo. Therefore, the Issuer has conveyed Manzo Pharmaceuticals, LLC back to Mr. Manzo in exchange for all of Mr. Manzo's common stock in the Issuer, two hundred million shares. This transfer leaves the Issuer without operations or a material amount of assets.
At present, the Issuer intends to start to study ways to increase shareholder value. There is no assurance that the Issuer will be successful in this endeavor.
Item 2: Changes in Control of Issuer
In connection with Mr. Manzo's departure from the Issuer, Mr. Manzo sold his Preferred stock in the Issuer. The 4,000,000 shares of Series A Preferred Stock formerly owned by Mr. Manzo is now owned by Gerasimos Alexander Antonios Morfesis.
Item 3: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
The Issuer has accepted Mr. Manzo's resignation as an officer and director of the Issuer. The 4,000,000 shares of Manzo Pharmaceuticals, Inc. Series A Preferred Stock have been conveyed to Gerasimos Alexander Antonios Morfesis.
Mr. Morfesis' address is 385 Whitcomb Boulevard, Tarpon Springs, Florida 34689. Mr. Morfesis is a real estate investor.
It is strange that nothing can be found on the SEC’s website.
A search for "manzo" finds 10 items stretching back to 2002, and none of them are Kenneth Manzo.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM